Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001883850-24-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-08-29 | 2024-08-28 | REGN | Fenimore Christopher R. | CFO, SVP Fin | S - Sale | $1,205.33 | -5,680 | 450 | -93% | -$6.85M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | S | D | 228 | $1,204.79 | 966 | I 2021 GRAT | — | — | (F1) Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-08-28 | S | D | 766 | $1,205.44 | 200 | I 2021 GRAT | — | — | (F2) Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-08-28 | S | D | 200 | $1,206.30 | 0 | I 2021 GRAT | — | — | (F3) Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-08-28 | S | D | 2,237 | $1,204.71 | 1,378 | I 2022 GRAT | — | — | (F4) Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-08-28 | S | D | 200 | $1,206.67 | 25 | I by Trust for Son | — | — | (F10) Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-08-28 | S | D | 450 | $1,206.15 | 0 | I 2022 GRAT | — | — | (F6) Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-08-28 | S | D | 236 | $1,205.67 | 225 | I by Trust for Daugh | — | — | (F7) Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-08-28 | S | D | 200 | $1,206.70 | 25 | I by Trust for Daugh | — | — | (F8) Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-08-28 | S | D | 235 | $1,205.67 | 225 | I by Trust for Son | — | — | (F9) Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-08-28 | S | D | 928 | $1,205.49 | 450 | I 2022 GRAT | — | — | (F5) Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price. |